Dr. Sewon Kang, MD

NPI: 1972690816
Total Payments
$32,719
2023 Payments
$2,837
Companies
9
Transactions
19
Medicare Patients
410
Medicare Billing
$20,631

Payment Breakdown by Category

Consulting$25,722 (78.6%)
Other$4,500 (13.8%)
Travel$1,713 (5.2%)
Food & Beverage$765.57 (2.3%)
Education$19.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,722 7 78.6%
Honoraria $4,500 1 13.8%
Travel and Lodging $1,713 3 5.2%
Food and Beverage $765.57 7 2.3%
Education $19.00 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Sun Pharmaceutical Industries Inc. $11,639 5 $0 (2019)
Allergan, Inc. $8,900 2 $0 (2021)
Almirall LLC $7,490 5 $0 (2019)
Eli Lilly and Company $2,817 2 $0 (2023)
Galderma Laboratories, L.P. $1,575 1 $0 (2021)
Ortho Dermatologics, a division of Bausch Health US, LLC $135.67 1 $0 (2018)
Kyowa Kirin, Inc. $123.36 1 $0 (2022)
E.R. Squibb & Sons, L.L.C. $20.18 1 $0 (2023)
Sandoz Inc. $19.00 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $2,837 3 Eli Lilly and Company ($2,817)
2022 $142.36 2 Kyowa Kirin, Inc. ($123.36)
2021 $6,475 2 Allergan, Inc. ($4,900)
2020 $4,000 1 Allergan, Inc. ($4,000)
2019 $19,129 10 Sun Pharmaceutical Industries Inc. ($11,639)
2018 $135.67 1 Ortho Dermatologics, a division of Bausch Health US, LLC ($135.67)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/22/2023 Eli Lilly and Company Consulting Fee Cash or cash equivalent $2,700.00 General
03/17/2023 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $20.18 General
03/16/2023 Eli Lilly and Company TALTZ (Drug) Food and Beverage In-kind items and services $116.66 General
Category: Immunology
09/30/2022 Sandoz Inc. Education In-kind items and services $19.00 General
07/26/2022 Kyowa Kirin, Inc. POTELIGEO (Drug) Food and Beverage In-kind items and services $123.36 General
Category: Monoclonal Antibody
02/23/2021 Galderma Laboratories, L.P. AKLIEF (Drug) Consulting Fee Cash or cash equivalent $1,575.00 General
Category: ACNE
01/19/2021 Allergan, Inc. Consulting Fee Cash or cash equivalent $4,900.00 General
07/07/2020 Allergan, Inc. Consulting Fee Cash or cash equivalent $4,000.00 General
10/30/2019 Sun Pharmaceutical Industries Inc. Consulting Fee Cash or cash equivalent $2,836.00 General
09/30/2019 Sun Pharmaceutical Industries Inc. Consulting Fee Cash or cash equivalent $2,836.00 General
03/16/2019 Sun Pharmaceutical Industries Inc. ABSORICA (Drug) Honoraria Cash or cash equivalent $4,500.00 General
Category: Dermatology
03/16/2019 Sun Pharmaceutical Industries Inc. ABSORICA (Drug) Travel and Lodging In-kind items and services $1,338.58 General
Category: Dermatology
03/16/2019 Sun Pharmaceutical Industries Inc. ABSORICA (Drug) Food and Beverage In-kind items and services $128.57 General
Category: Dermatology
03/02/2019 Almirall LLC Food and Beverage Cash or cash equivalent $36.66 General
01/16/2019 Almirall LLC Consulting Fee Cash or cash equivalent $6,875.00 General
01/16/2019 Almirall LLC Travel and Lodging Cash or cash equivalent $319.00 General
01/16/2019 Almirall LLC Food and Beverage Cash or cash equivalent $204.47 General
01/16/2019 Almirall LLC Travel and Lodging Cash or cash equivalent $54.96 General
11/14/2018 Ortho Dermatologics, a division of Bausch Health US, LLC SILIQ (Drug) Food and Beverage In-kind items and services $135.67 General
Category: DERMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 136 168 $34,163 $6,482
2022 4 84 97 $21,172 $4,673
2021 5 112 149 $24,439 $5,593
2020 3 78 82 $20,466 $3,884
Total Patients
410
Total Services
496
Medicare Billing
$20,631
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 46 54 $10,828 $2,637 24.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 20 20 $6,065 $1,511 24.9%
17000 Destruction of precancer skin growth, 1 growth Facility 2023 21 23 $5,035 $982.83 19.5%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 15 15 $4,527 $848.52 18.7%
11102 Biopsy of related skin growth, first growth Facility 2023 20 20 $6,700 $441.11 6.6%
17003 Destruction of precancer skin growth, 2-14 growths Facility 2023 14 36 $1,008 $61.29 6.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 44 51 $9,114 $2,530 27.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 13 15 $3,991 $1,138 28.5%
17000 Destruction of precancer skin growth, 1 growth Facility 2022 11 13 $2,525 $550.98 21.8%
11102 Biopsy of related skin growth, first growth Facility 2022 16 18 $5,542 $454.00 8.2%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 48 55 $9,570 $2,861 29.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 16 19 $4,883 $1,500 30.7%
17000 Destruction of skin growth Facility 2021 17 17 $3,196 $642.48 20.1%
11102 Tangential biopsy of single skin lesion Facility 2021 19 21 $5,754 $526.40 9.1%
17003 Destruction of 2-14 skin growths Facility 2021 12 37 $1,036 $62.56 6.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 49 52 $13,364 $2,855 21.4%
17000 Destruction of skin growth Facility 2020 12 13 $2,444 $546.26 22.4%
11102 Tangential biopsy of single skin lesion Facility 2020 17 17 $4,658 $482.33 10.4%

About Dr. Sewon Kang, MD

Dr. Sewon Kang, MD is a Dermatology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972690816.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sewon Kang, MD has received a total of $32,719 in payments from pharmaceutical and medical device companies, with $2,837 received in 2023. These payments were reported across 19 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($25,722).

As a Medicare-enrolled provider, Kang has provided services to 410 Medicare beneficiaries, totaling 496 services with total Medicare billing of $20,631. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Other Specialties Dermatology
  • Location Baltimore, MD
  • Active Since 10/10/2006
  • Last Updated 09/13/2022
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1972690816

Products in Payments

  • ABSORICA (Drug) $5,967
  • AKLIEF (Drug) $1,575
  • SILIQ (Drug) $135.67
  • POTELIGEO (Drug) $123.36
  • TALTZ (Drug) $116.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Baltimore